Übersichtsarbeit
Novel Adjuvant Systems
Current Drug Target -Infectious Disorders · 2001
DOI: 10.2174/1568005014605991 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, 2001. Verfasst von M J McCluskie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Coley Pharmaceutical Canada, 725 Parkdale Avenue, Ottawa, K1Y 4E9, Canada. mmccluskie@coleypharma.com. Die Arbeit wurde bisher 45-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Acetylmuramyl-Alanyl-IsoglutamineAdjuvants, ImmunologicAnimalsBacterial ToxinsCalcitriolCytokinesCytoskeletal ProteinsDrug CombinationsHumansLipid AOligodeoxyribonucleotidesSaponinsVaccines
Substanzen
Adjuvants, ImmunologicBacterial ToxinsCPG-oligonucleotideCytokinesCytoskeletal ProteinsDrug CombinationsLipid AOligodeoxyribonucleotidesSaponinsVaccines
Autor:innen und Institutionen
- Coley Pharmaceutical Canada, 725 Parkdale Avenue, Ottawa, K1Y 4E9, Canada. mmccluskie@coleypharma.com
Zitieren
APA
McCluskie, M. J., & Weeratna, R. D. (2001). Novel Adjuvant Systems. Current Drug Target -Infectious Disorders. https://doi.org/10.2174/1568005014605991
Vancouver
McCluskie MJ, Weeratna RD. Novel Adjuvant Systems. Current Drug Target -Infectious Disorders. 2001. doi:10.2174/1568005014605991
BibTeX
@article{McCluskie2001,
author = {McCluskie, M J and Weeratna, R D},
title = {Novel Adjuvant Systems},
journal = {Current Drug Target -Infectious Disorders},
year = {2001},
doi = {10.2174/1568005014605991}
}
EUVIMED